bioRxivCell Biology
Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity
L. T. Bui, N. I. Winters, M.-I. Chung, C. Joseph, A. J. Gutierrez, A. C. Habermann, T. S. Adams, J. C. Schupp, S. Poli, L. M. Peter, C. J. Taylor, J. B. Blackburn, B. W. Richmond, A. G. Nicholson, D. Rassl, W. A. Wallace, I. O. Rosas, R. G. Jenkins, N. Kaminski, J. A. Kropski, N. E. Banovich, Human Cell Atlas Lung Biological Network
Abstract
Patients with chronic lung disease (CLD) have an increased risk for severe coronavirus disease-19 (COVID-19) and poor outcomes. Here, we analyzed the transcriptomes of 605,904 single cells isolated from healthy and CLD lungs to identify molecular characteristics of lung cells that may account for worse COVID-19 outcomes in patients with chronic lung diseases. We observed a similar cellular distribution and relative expression of SARS-CoV-2 entry factors in control and CLD lungs. CLD epithelial cells expressed higher levels of genes linked directly to the efficiency of viral replication and innate immune response. Additionally, we identified basal differences in inflammatory gene expression programs that highlight how CLD alters the inflammatory microenvironment encountered upon viral exposure to the peripheral lung. Our study indicates that CLD is accompanied by changes in cell-type-specific gene expression programs that prime the lung epithelium for and influence the innate and adaptive immune responses to SARS-CoV-2 infection.
- organism: human
- assay: scRNA-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Lung spatial profiling reveals a T cell signature in COPD patients with fatal SARS-CoV-2 infection
C. X. Yang, M. Tomchaney, … F. Polverino·bioRxiv·Apr 20, 2022
- Comprehensive Transcriptomic Analysis of COVID-19 Blood, Lung, and Airway
A. R. Daamen, P. Bachali, … P. E. Lipsky·bioRxiv·May 28, 2020
- Lung biopsy cells transcriptional landscape from COVID-19 patient stratified lung injury in SARS-CoV-2 infection through impaired pulmonary surfactant metabolism
Abul Bashar Mir Md. Khademul Islam, Md. Abdullah‐Al‐Kamran Khan·Scientific ReportsPeer-reviewed·Nov 10, 2020
- Paradoxical effects of cigarette smoke and COPD on SARS-CoV2 infection and disease
M. Tomchaney, M. Contoli, … F. Polverino·bioRxiv·Dec 7, 2020
- Longitudinal host transcriptional responses to SARS-CoV-2 infection in adults with extremely high viral load
V. Avadhanula, C. J. Creighton, … P. A. Piedra·bioRxiv·May 24, 2023
- Single-cell analysis of lung epithelial cells reveals age and cell population-specific responses to SARS-CoV-2 infection in ciliated cells
Raven M. Osborn, Christopher Anderson, … Juilee Thakar·Clinical & Experimental ImmunologyPeer-reviewed·Dec 6, 2024